Paying users zone. Data is covered by 
.
Get to Eli Lilly & Co. for $17.99, or
get to whole website for at least 3 months from $49.99.
Selected Financial Data
since 2005
Difficulty: Beginner
Income Statement
Eli Lilly & Co., selected income statement items, long-term trends
USD $ in thousands
| 12 months ended | Revenue | Net income (loss) |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Assets
Eli Lilly & Co., selected asset items, long-term trends
USD $ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Liabilities and Stockholders' Equity
Eli Lilly & Co., liabilities and stockholders' equity selected items, long-term trends
USD $ in thousands
| Current liabilities | Total liabilities | Total debt | Total Eli Lilly and Company shareholders' equity | |
|---|---|---|---|---|
| Dec 31, 2005 | |
|
|
|
| Dec 31, 2006 | |
|
|
|
| Dec 31, 2007 | |
|
|
|
| Dec 31, 2008 | |
|
|
|
| Dec 31, 2009 | |
|
|
|
| Dec 31, 2010 | |
|
|
|
| Dec 31, 2011 | |
|
|
|
| Dec 31, 2012 | |
|
|
|
| Dec 31, 2013 | |
|
|
|
| Dec 31, 2014 | |
|
|
|
| Dec 31, 2015 | |
|
|
|
| Dec 31, 2016 | |
|
|
|
| Dec 31, 2017 | |
|
|
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Statement of Cash Flows
Eli Lilly & Co., selected statement of cash flows items, long-term trends
USD $ in thousands
| 12 months ended | Net cash provided by operating activities | Net cash (used for) provided by investing activities | Net cash provided by (used for) financing activities |
|---|---|---|---|
| Dec 31, 2005 | |
|
|
| Dec 31, 2006 | |
|
|
| Dec 31, 2007 | |
|
|
| Dec 31, 2008 | |
|
|
| Dec 31, 2009 | |
|
|
| Dec 31, 2010 | |
|
|
| Dec 31, 2011 | |
|
|
| Dec 31, 2012 | |
|
|
| Dec 31, 2013 | |
|
|
| Dec 31, 2014 | |
|
|
| Dec 31, 2015 | |
|
|
| Dec 31, 2016 | |
|
|
| Dec 31, 2017 | |
|
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Per Share Data
Eli Lilly & Co., selected per share data, long-term trends
USD $
| 12 months ended | Basic Earnings Per Share 1 | Diluted Earnings Per Share 2 | Dividend Per Share 3 |
|---|---|---|---|
| Dec 31, 2005 | |
|
|
| Dec 31, 2006 | |
|
|
| Dec 31, 2007 | |
|
|
| Dec 31, 2008 | |
|
|
| Dec 31, 2009 | |
|
|
| Dec 31, 2010 | |
|
|
| Dec 31, 2011 | |
|
|
| Dec 31, 2012 | |
|
|
| Dec 31, 2013 | |
|
|
| Dec 31, 2014 | |
|
|
| Dec 31, 2015 | |
|
|
| Dec 31, 2016 | |
|
|
| Dec 31, 2017 | |
|
|
1, 2, 3 Data adjusted for splits and stock dividends.
Source: Based on data from Eli Lilly & Co. Annual Reports
